Vivani Medical Inc is a preclinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VANI is expected to report earnings to fall 13.64% to -9 cents per share on August 19
Q2'25
Est.
$-0.09
Q1'25
Missed
by $0.01
Q4'24
Est.
$-0.11
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.02
The last earnings report on May 13 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 61.61K shares outstanding, the current market capitalization sits at 66.95M.